MARC record from Internet Archive

LEADER: 05976cam 2200769Ma 4500
001 ocn646758591
003 OCoLC
005 20220624224312.0
008 750720s1976 nyu ob 001 0 eng d
006 m o d
007 cr cn|||||||||
010 $z 59013823
040 $aE7B$beng$epn$cE7B$dOCLCQ$dN$T$dIDEBK$dOCLCQ$dOPELS$dOCLCQ$dOCLCF$dYDXCP$dOCLCQ$dDEBBG$dOTZ$dLEAUB$dVLY$dOCLCO
019 $a297547402$a1162395369
020 $a9780080564340$q(electronic bk.)
020 $a0080564348$q(electronic bk.)
020 $a0120026201$q(electronic bk.)
020 $a9780120026203$q(electronic bk.)
020 $a9786611738143
020 $a6611738142
035 $a(OCoLC)646758591$z(OCoLC)297547402$z(OCoLC)1162395369
050 4 $aQR1$b.A3820 1976eb
072 7 $aMED$x052000$2bisacsh
082 04 $a660.6/2$222
245 00 $aAdvances in applied microbiology$nVolume 20 /$cedited by D. Perlman.
246 30 $aApplied microbiology
260 $aNew York :$bAcademic Press,$c1976.
300 $a1 online resource (ix, 381 pages).
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aAdvances in applied microbiology ;$v20
504 $aIncludes bibliographical references and index.
588 0 $aPrint version record.
505 0 $aFront Cover; Advances in Applied Microbiology, Volume 20; Copyright Page; Contents; List of Contributors; Chapter 1. The Current Status of Pertussis Vaccine: An Overview; Text; Chapter 2. Biologically Active Components and Properties of Bordetella pertussis; I. Introduction; II. Sensitization to Histamine; III. ß-Adrenergic Blockade; IV. Lymphocytosis-Promoting Factor; V. Adjuvanticity; VI. Lipopolysaccharide Endotoxin; VII. Heat-Labile Toxin; VIII. Hemagglutinin; IX. Mitogenicity for Lymphocytes; X. Interrelationships between Biological Activities; XI. Pathogenesis of Pertussis; References
505 8 $aChapter 3. Role of the Genetics and Physiology of Bordetella pertussis in the Production of Vaccine and the Study of Host-Parasite Relationships in PertussisI. Introduction; II. Genetics; III. Physiology; References; Chapter 4. Problems Associated with the Development and Clinical Testing of an Improved Pertussis Vaccine; I. Do We Need an Improved Pertussis Vaccine?; II. Why Don't We Have an Improved or Fully Acceptable Pertussis Vaccine Now?; III. Where Do We Go From Here with the Development of an Improved Pertussis Vaccine?
505 8 $aIV. Can We Really Expect to Get New Pertussis Vaccines Approved, Marketed, and in General Distribution?References; Chapter 5. Problems Associated with the Control Testing of Pertussis Vaccine; I. Introduction; II. Colonial Variation in Bordetella pertussis; III. Opacity Standards; IV. Potency Assay; V. Role of Adjuvant; VI. Agglutinins; VII. Toxicity; VIII. Summary; References; Chapter 6. Vinegar: Its History and Development; I. Introduction; II. In the Beginning; III. Nonfood Uses of Vinegar through the Centuries; IV. Vinegar in Food Processing; V. Production Methods
505 8 $aVI. Major Types of VinegarVII. The Industry; VIII. Microbiology of Vinegar Production; IX. Mechanism of the Biological Conversion of Ethanol to Acetic Acid; X. Composition of Vinegar; XI. Summary; References; Chapter 7. Microbial Rennets; I. Introduction; II. Microbial Rennets from Endothla parasitica. Mucor miehei, and Mucor pusillus var. Lindt; III. Screening for New Microbial Rennets; IV. Conclusions; References; Chapter 8. Biosynthesis of Cephalosporins; I. Introduction; II. Occurrence of Cephalosporins and Related Metabolites; III. Genetic Studies and Strain Improvement
505 8 $aIV. FermentationV. Biosynthesis; VI. Enzymes Related to Cephalosporin Metabolism; VII. Conclusions; References; Chapter 9. Preparation of Pharmaceutical Compounds by Immobilized Enzymes and Cells; I. Introduction; II. Penicillins; III Cephalosporins; IV. Amino Acids; V. Other Products; VI. Concluding Remarks; References; Chapter 10. Cytotoxic and Antitumor Antibiotics Produced by Microorganisms; I. Introduction; II. Antibiotics and Their Synonyms; III. List of Tumors; References; SUBJECT INDEX; CONTENTS OF PREVIOUS VOLUMES
520 $aADVANCES IN APPLIED MICROBIOLOGY VOL 20.
546 $aEnglish.
650 0 $aMicrobiology$xResearch.
650 0 $aMicrobiology.
650 6 $aMicrobiologie.
650 7 $amicrobiology.$2aat
650 7 $aMEDICAL$xMicrobiology.$2bisacsh
650 7 $aMicrobiology.$2fast$0(OCoLC)fst01019576
650 7 $aMicrobiology$xResearch.$2fast$0(OCoLC)fst01019590
650 7 $aMicrobiologie industrielle.$2ram
655 4 $aElectronic books.
700 1 $aPerlman, D.,$d1920-
776 08 $iPrint version:$tAdvances in applied microbiology.$dNew York : Academic Press, 1976$w(DLC) 59013823
830 0 $aAdvances in applied microbiology ;$v20.
856 40 $3ebrary$uhttp://site.ebrary.com/id/10244299
856 40 $3EBSCOhost$uhttp://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=249505
856 40 $3MyiLibrary$uhttp://www.myilibrary.com?id=173814
856 40 $3ScienceDirect$uhttp://www.sciencedirect.com/science/book/9780120026203
856 4 $uhttp://www.sciencedirect.com/science/bookseries/00652164/20$xVerlag$zURL des Erstveröffentlichers$3Volltext
856 40 $3ScienceDirect$uhttps://login.proxy.bib.uottawa.ca/login?url=https://www.sciencedirect.com/science/book/9780120026203$zScienceDirect (Restricted to University of Ottawa)
856 40 $3ScienceDirect$uhttps://ezproxy.aub.edu.lb/login?url=http://www.sciencedirect.com/science/book/9780120026203$zClick for electronic access to e-book.
938 $aebrary$bEBRY$nebr10244299
938 $aEBSCOhost$bEBSC$n249505
938 $aYBP Library Services$bYANK$n2902372
029 1 $aCHBIS$b010354145
029 1 $aCHVBK$b329754521
994 $aZ0$bIME
948 $hNO HOLDINGS IN IME - 25 OTHER HOLDINGS